港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

药捷安康-B

196.400

-7.800-3.82%

成交量：54.56万

成交额：1.08亿

市值：779.71亿

市盈率：-249.54

高：206.000

开：203.000

低：194.500

收：204.200

52周最高：679.500

52周最低：20.200

股本：3.97亿

香港流通股本：3.02亿

量比：0.36

换手率：0.18%

股息：- -

股息率：- -

每股收益(LYR):-0.787

净资产收益率：-39.08%

总资产收益率：-21.10%

市净率：122.45

市盈率(LYR):-249.54

市销率: - -

数据加载中...

总览公司新闻资讯公告

药捷安康-B(02617)与Neurocrine达成项目合作

药捷安康-B与Neurocrine Biosciences Inc达成Nlrp3抑制剂合作

药捷安康-B10月31日主力净流入719.0万元散户资金抛售

药捷安康-B10月24日主力净流入207.0万元散户资金抛售

港股异动 | 生物技术股走弱，荣昌生物跌近12%

老虎资讯综合

港股医药板块再现异动拉升，多只个股走出亮眼行情！

港股异动 | 药捷安康-B(02617)一度涨超25% 于2025年ESMO年会上公布替恩戈替尼研究数据并获口头报告

港股速报 | 后劲不足港股冲高回落如何“御寒”

每日经济新闻

药捷安康-B(02617.HK)盘中跌超11%

每日经济新闻

生育津贴加速发放至个人；全球首套脑机交互定制化磁共振平台启用

21世纪经济报道

药捷安康-B(02617)拟实行H股全流通

港股医药股走强永泰生物涨近15%

每日经济新闻

从679元到112元，再回到224元：药捷安康-B（02617）是谁在“造神”？

一周港股牛熊榜 | 药捷安康一周飙近70%成“最靓的仔”；蚂蚁收购耀才再有新消息、耀才股价升19%；老铺黄金卖断货股价升18%

老虎资讯综合

药捷安康-B “鱿鱼游戏2”

生物科技股逆市有支撑康宁杰瑞制药-B(09966)涨6.57% 机构指中国创新药正在“量变引起质变”

药捷安康-B盘初涨幅扩大至逾30%，近两个交易日累涨95%

老虎资讯综合

港股生物医药股延续昨日强势，药捷安康-B涨超15%

老虎资讯综合

ETF龙虎榜 | 6只产品跻身涨幅前十！这类ETF普涨

妖股，“卷土重来”？

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02617/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"药捷安康-B","latestPrice":196.4,"timestamp":1763366893755,"preClose":204.2,"halted":0,"volume":545610,"delay":0,"floatShares":301666673,"shares":397000000,"eps":-0.7870374953430878,"marketStatus":"未开盘","change":-7.8,"latestTime":"11-17 16:08:13","open":203,"high":206,"low":194.5,"amount":107768274,"amplitude":0.056317,"askPrice":196.4,"askSize":4000,"bidPrice":196.3,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-0.6789723591731065,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1763429400000},"marketStatusCode":0,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":204.2,"openAndCloseTimeList":[[1763343000000,1763352000000],[1763355600000,1763366400000]],"volumeRatio":0.3626473194524195,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":301666673,"roa":"-21.10%","roe":"-39.08%","lyrEps":-0.787037,"volumeRatio":0.3626473194524195,"shares":397000000,"dividePrice":0,"high":206,"amplitude":0.056317,"preClose":204.2,"low":194.5,"week52Low":20.2,"pbRate":"122.45","week52High":679.5,"institutionHeld":0,"latestPrice":196.4,"committee":-0.777778,"eps":-0.7870374953430878,"divideRate":0,"volume":545610,"delay":0,"ttmEps":-0.6789723591731065,"open":203,"prevYearClose":13.15,"prevWeekClose":204.2,"prevMonthClose":183.8,"prevQuarterClose":141.2,"fiveDayClose":233,"twentyDayClose":203,"sixtyDayClose":51.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2025-11-14","current":-289.313297,"percent":0.079208,"low":-380.446233,"twenty":-262.893893,"median":-70.289151,"eighty":-42.482614,"high":-17.403134,"avg":-136.990218,"sd":107.716882,"marketCap":81046496658},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-27","current":-36.622688,"twenty":-34.709071,"median":-32.493198,"eighty":-31.066553,"marketCap":11013909315},{"date":"2025-07-04","current":-44.802949,"twenty":-38.622694,"median":-35.660049,"eighty":-31.776499,"marketCap":13474674640},{"date":"2025-07-11","current":-39.630155,"twenty":-40.38446,"median":-38.336544,"eighty":-32.816725,"marketCap":11906928990},{"date":"2025-07-18","current":-43.957869,"twenty":-42.111612,"median":-39.630155,"eighty":-34.373739,"marketCap":13196846297},{"date":"2025-07-25","current":-49.067594,"twenty":-42.195906,"median":-40.285196,"eighty":-36.230637,"marketCap":14784436829},{"date":"2025-08-01","current":-50.963195,"twenty":-45.655878,"median":-41.371359,"eighty":-36.620356,"marketCap":15260713988},{"date":"2025-08-08","current":-58.015216,"twenty":-51.234741,"median":-42.017389,"eighty":-37.993773,"marketCap":17415868136},{"date":"2025-08-15","current":-66.867935,"twenty":-57.065221,"median":-42.261724,"eighty":-38.707864,"marketCap":20043330466},{"date":"2025-08-22","current":-72.723484,"twenty":-59.09189,"median":-43.957869,"eighty":-39.464263,"marketCap":21730145406},{"date":"2025-08-29","current":-49.610789,"twenty":-64.458089,"median":-47.896219,"eighty":-39.630155,"marketCap":21492006826},{"date":"2025-09-05","current":-57.867887,"twenty":-63.405379,"median":-50.300475,"eighty":-39.739866,"marketCap":25044240642},{"date":"2025-09-12","current":-176.221101,"twenty":-67.557018,"median":-51.642061,"eighty":-40.181616,"marketCap":76402794352},{"date":"2025-09-19","current":-137.321051,"twenty":-71.134174,"median":-54.042597,"eighty":-40.68225,"marketCap":59494955186},{"date":"2025-09-26","current":-219.814439,"twenty":-72.736767,"median":-55.62397,"eighty":-41.23574,"marketCap":56835741045},{"date":"2025-10-03","current":-208.418403,"twenty":-113.88308,"median":-57.213624,"eighty":-41.375772,"marketCap":54017767851},{"date":"2025-10-10","current":-183.264838,"twenty":-172.633767,"median":-57.790453,"eighty":-41.583173,"marketCap":47429267143},{"date":"2025-10-17","current":-311.562728,"twenty":-178.967921,"median":-58.015216,"eighty":-41.927636,"marketCap":80570219499},{"date":"2025-10-24","current":-293.038662,"twenty":-206.454369,"median":-63.574223,"eighty":-42.029097,"marketCap":75807447903},{"date":"2025-10-31","current":-281.572204,"twenty":-212.338922,"median":-65.741367,"eighty":-42.067733,"marketCap":72949784945},{"date":"2025-11-07","current":-338.772318,"twenty":-240.199465,"median":-68.232426,"eighty":-42.195906,"marketCap":87714376893},{"date":"2025-11-14","current":-312.135011,"twenty":-262.893893,"median":-70.289151,"eighty":-42.482614,"marketCap":81046496658}],"updateTime":1763395922913},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02617\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2580230834","title":"药捷安康-B(02617)与Neurocrine达成项目合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2580230834","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580230834?lang=zh_cn&edition=fundamental","pubTime":"2025-11-03 08:17","pubTimestamp":1762129069,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药捷安康-B 发布公告，Neurocrine Biosciences, Inc.与本公司订立一项付特许权使用费的专利转让及研究合作协议，以开发NLRP3抑制剂，用于治疗多种疾病(该协议)。根据该协议，公司将有权获得预付款，并且根据Neurocrine的开发和商业化进展，公司可能会收到与研发里程碑和销售里程碑相关的进一步里程碑付款，该协议的总潜在价值为 8.815亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364214.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药捷安康-B(02617)与Neurocrine达成项目合作","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"1108119128","title":"药捷安康-B与Neurocrine Biosciences Inc达成Nlrp3抑制剂合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1108119128","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108119128?lang=zh_cn&edition=fundamental","pubTime":"2025-11-03 08:06","pubTimestamp":1762128409,"startTime":"0","endTime":"0","summary":"药捷安康-B与Neurocrine Biosciences Inc达成Nlrp3抑制剂合作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2580453324","title":"药捷安康-B10月31日主力净流入719.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2580453324","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580453324?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 16:15","pubTimestamp":1761898534,"startTime":"0","endTime":"0","summary":"10月31日, 药捷安康-B股价涨5.88%，报收183.80元，成交金额7.0亿元，换手率1.25%，振幅15.84%，量比1.73。药捷安康-B今日主力资金净流入719.0万元，上一交易日主力净流出0万元。该股近5个交易日下跌2.13%，主力资金累计净流入925.9万元；近20日主力资金累计净流入2151.7万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031161916974beb07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031161916974beb07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2577518085","title":"药捷安康-B10月24日主力净流入207.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2577518085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577518085?lang=zh_cn&edition=fundamental","pubTime":"2025-10-24 16:15","pubTimestamp":1761293722,"startTime":"0","endTime":"0","summary":"10月24日, 药捷安康-B股价涨1.70%，报收191.00元，成交金额7.6亿元，换手率1.31%，振幅13.68%，量比0.63。药捷安康-B今日主力资金净流入207.0万元，上一交易日主力净流出928.1万元。该股近5个交易日下跌5.42%，主力资金累计净流入1101.7万元；近20日主力资金累计净流入769.1万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102416164094db34b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102416164094db34b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"1152404472","title":"港股异动 | 生物技术股走弱，荣昌生物跌近12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152404472","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152404472?lang=zh_cn&edition=fundamental","pubTime":"2025-10-23 13:25","pubTimestamp":1761197137,"startTime":"0","endTime":"0","summary":"10月23日，港股$生物(000504)$技术股盘中走弱，$荣昌生物(09995)$跌近12%，$药捷安康-B(02617)$跌超8%，$科伦博泰生物-B(06990)$跌超6%，$晶泰控股(02228)$、$映恩生物-B(09606)$跌近6%，$药明生物(02269)$、$康方生物(09926)$、$百济神州(06160)$跟跌。","market":"us","thumbnail":"https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"df43def6c60d84e15ce9d1605944911d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926","06990","02269","02228","02617","09995","ONC","09606","06160"],"gpt_icon":0},{"id":"2577335143","title":"港股医药板块再现异动拉升，多只个股走出亮眼行情！","url":"https://stock-news.laohu8.com/highlight/detail?id=2577335143","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577335143?lang=zh_cn&edition=fundamental","pubTime":"2025-10-22 11:25","pubTimestamp":1761103512,"startTime":"0","endTime":"0","summary":"10月22日，港股医药板块再现异动拉升，多只个股走出亮眼行情。政策层面的积极导向也为港股医药股的走强提供了重要保障。从市场节奏来看，当前港股医药股的上涨具备坚实的催化剂支撑。对于市场而言，港股医药股的强势行情不仅是短期资金推动的结果，更反映出产业长期发展逻辑的重构。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102211310194d6f0ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102211310194d6f0ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09926","BK1574","06978","BK1161","01530","02617","02898","01276"],"gpt_icon":0},{"id":"2577387025","title":"港股异动 | 药捷安康-B(02617)一度涨超25% 于2025年ESMO年会上公布替恩戈替尼研究数据并获口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2577387025","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577387025?lang=zh_cn&edition=fundamental","pubTime":"2025-10-22 09:53","pubTimestamp":1761098036,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，药捷安康-B一度涨超25%，截至发稿，涨15.81%，报200港元，成交额7.12亿港元。消息面上，据药捷安康官微消息，10月20日，药捷安康宣布，公司在2025年欧洲肿瘤内科学会年会上公开了核心产品替恩戈替尼于胆管癌适应症的最新汇总研究数据。据悉，替恩戈替尼是一款自主研发、注册性临床阶段的创新多靶点小分子激酶抑制剂，通过靶向肿瘤细胞和改善肿瘤微环境发挥抗肿瘤作用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357913.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"港股异动 | 药捷安康-B(02617)一度涨超25% 于2025年ESMO年会上公布替恩戈替尼研究数据并获口头报告","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2577280698","title":"港股速报 | 后劲不足 港股冲高回落 如何“御寒”","url":"https://stock-news.laohu8.com/highlight/detail?id=2577280698","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577280698?lang=zh_cn&edition=fundamental","pubTime":"2025-10-21 17:14","pubTimestamp":1761038056,"startTime":"0","endTime":"0","summary":"今日（10月21日），港股市场一度高开高走，但下午明显后劲不足，最终各类指数冲高回落。截至收盘，恒指报收于26027.55点，上涨168.72点，涨幅0.65%。恒生科技指数报收于6007.94点，上涨74.77点，涨幅1.26%。市场方面，随着近期气候逐渐进入冬季，如何御寒备受关注，而“温暖”赛道开始成为热点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202510213540011819.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510213540011819.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01088","02617","BK1178","BK1502","LU0287142896.SGD","BK1589","06885","BK1161","LU0173614495.USD","LU1675838814.USD","BK1538","BK1594","BK1225","BK1505","BK1512","BK1227","BK1500","03998","LU1808992512.USD"],"gpt_icon":0},{"id":"2577684439","title":"药捷安康-B(02617.HK)盘中跌超11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577684439","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577684439?lang=zh_cn&edition=fundamental","pubTime":"2025-10-21 15:38","pubTimestamp":1761032330,"startTime":"0","endTime":"0","summary":"每经AI快讯，药捷安康-B(02617.HK)盘中跌超11%，截至发稿，跌9.74%，报176.2港元，成交额5.91亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202510213539907874.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510213539907874.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2577489082","title":"生育津贴加速发放至个人；全球首套脑机交互定制化磁共振平台启用","url":"https://stock-news.laohu8.com/highlight/detail?id=2577489082","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577489082?lang=zh_cn&edition=fundamental","pubTime":"2025-10-21 07:59","pubTimestamp":1761004742,"startTime":"0","endTime":"0","summary":"政策动向国家医保局：预计到11月1日25省份、近九成统筹区实现生育津贴直接发放至个人10月20日，据国家医保局消息，自9月以来，江西、安徽、陕西等省陆续在全省推开生育津贴直接发放至个人。辽宁、江苏已于近日正式发文，将于11月1日起在全省实现生育津贴直达个人。预计到11月1日，全国将有25个省份（含新疆生产建设兵团）实现生育津贴直接发放至个人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202510213539281163.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510213539281163.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1100","BK1161","09996","BK1222","02617","BK1574","BK1583","09997"],"gpt_icon":0},{"id":"2576483767","title":"药捷安康-B(02617)拟实行H股全流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2576483767","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576483767?lang=zh_cn&edition=fundamental","pubTime":"2025-10-20 17:49","pubTimestamp":1760953755,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药捷安康-B(02617)发布公告，于2025年10月20日，公司董事会已考虑及批准向中国证监会提交申请，将公司10名股东持有的4497.11万股公司内资股转换为公司H股，占公司于本公告日期已发行股份总数约11.33%。于取得所有相关批准(包括中国证监会及联交所的批准)并遵守所有适用法律、法规及规则后，该等内资股将转换为H股，并符合资格于联交所主板上市及买卖。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357128.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药捷安康-B(02617)拟实行H股全流通","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2576833918","title":"港股医药股走强 永泰生物涨近15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576833918","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576833918?lang=zh_cn&edition=fundamental","pubTime":"2025-10-20 09:36","pubTimestamp":1760924207,"startTime":"0","endTime":"0","summary":"每经AI快讯，10月20日，截至发稿，永泰生物-B(06978.HK)涨14.94%、和珀医药-B(02142.HK)涨5.32%、荣昌生物(09995.HK)涨5.14%、药捷安康(02617.HK)涨5.02%、基石药业-B(02616.HK)涨3.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202510203538408552.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510203538408552.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","LU2328871848.SGD","02617","06978","BK1161","09995","02616","BK1574","02142","LU1969619763.USD"],"gpt_icon":0},{"id":"2576034700","title":"从679元到112元，再回到224元：药捷安康-B（02617）是谁在“造神”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2576034700","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576034700?lang=zh_cn&edition=fundamental","pubTime":"2025-10-17 19:34","pubTimestamp":1760700846,"startTime":"0","endTime":"0","summary":"近期，药捷安康-B再次上演了一出“不安康”剧本。这短短的7个交易日，足以载入药捷安康的“史册”。593.40%的涨幅，620.72%的振幅。两大港股通渠道在短短7个交易日内，合计增持超过306万股，新增持股比例高达1.0152%。此外，浦银国际证券减持比例约为0.5561%，期末持股仅剩5万股。股价从高点679.50元惨烈回落，最高跌幅超过72%。基于以上分析，药捷安康本轮暴力反弹是一次由国际短线游资发动，但被内地主力资金利用作为“出货窗口”的反弹。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1356559.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02617"],"gpt_icon":1},{"id":"1136396930","title":"一周港股牛熊榜 | 药捷安康一周飙近70%成“最靓的仔”；蚂蚁收购耀才再有新消息、耀才股价升19%；老铺黄金卖断货股价升18%","url":"https://stock-news.laohu8.com/highlight/detail?id=1136396930","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136396930?lang=zh_cn&edition=fundamental","pubTime":"2025-10-17 18:23","pubTimestamp":1760696603,"startTime":"0","endTime":"0","summary":"9月以来，老铺黄金加速拓展新门店。集团已就俄罗斯法院裁决提出上诉，目前评估显示撤销决定暂未对日常营运造成重大影响。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09900","06181","06869","03633","02367","00376","02617","00189","01428","01142"],"gpt_icon":1},{"id":"2576084122","title":"药捷安康-B “鱿鱼游戏2”","url":"https://stock-news.laohu8.com/highlight/detail?id=2576084122","media":"多肽链","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576084122?lang=zh_cn&edition=fundamental","pubTime":"2025-10-17 11:22","pubTimestamp":1760671364,"startTime":"0","endTime":"0","summary":"10月16日，药捷安康-B当日暴涨46.34%，公司市值一日净增200亿港元，收盘价对应市值659亿港元。虽然很难从公司基本面上归因出药捷安康-B股价的暴涨怒跌，但起码可以倒推出这场“鱿鱼游戏”中，资本“注水”能有多离谱。就药捷安康-B而言，最核心也是最接近上市的创新药就是用于肿瘤治疗的替恩戈替尼，也就是前述的“TT-00420”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017130631a6be3afe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017130631a6be3afe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2576709834","title":"生物科技股逆市有支撑 康宁杰瑞制药-B(09966)涨6.57% 机构指中国创新药正在“量变引起质变”","url":"https://stock-news.laohu8.com/highlight/detail?id=2576709834","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576709834?lang=zh_cn&edition=fundamental","pubTime":"2025-10-17 10:17","pubTimestamp":1760667435,"startTime":"0","endTime":"0","summary":"华福证券指出，即将召开的欧洲肿瘤内科学会年会上公布的中国创新药临床数据，预计会成为市场主要关注点，也建议关注三季度业绩报告的披露和11月的国家医保谈判。该行表示，中国创新药正在“量变引起质变”，看好创新药5-10年的产业趋势，BD出海、持续数据催化和新产品销售放量将依次推动创新药崛起。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1967991","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","HK0000500386.USD","02410","BK1161","02616","02617","09966","159837","BK1574","LU2543165471.USD","02197","HK0000252160.HKD","06978","HK0000252152.HKD","159992","09606","02509"],"gpt_icon":0},{"id":"1169694126","title":"药捷安康-B盘初涨幅扩大至逾30%，近两个交易日累涨95%","url":"https://stock-news.laohu8.com/highlight/detail?id=1169694126","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169694126?lang=zh_cn&edition=fundamental","pubTime":"2025-10-17 09:44","pubTimestamp":1760665457,"startTime":"0","endTime":"0","summary":"10月17日，$药捷安康-B(02617)$盘初涨幅扩大至逾30%，成交额超7亿港元，该股近两个交易日累涨95%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"68a44e2aeed9ba7083b4ebfed1ca6b2b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","BK1161"],"gpt_icon":0},{"id":"1134247132","title":"港股生物医药股延续昨日强势，药捷安康-B涨超15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1134247132","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134247132?lang=zh_cn&edition=fundamental","pubTime":"2025-10-17 09:32","pubTimestamp":1760664754,"startTime":"0","endTime":"0","summary":"生物医药股延续昨日强势，$药捷安康-B(02617)$涨超15%，$百奥赛图-B(02315)$涨超10%，$基石药业-B(02616)$涨超7%，$康宁杰瑞制药-B(09966)$涨超6%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"fc7ccc68210fffcf55d2ffc6613e5571","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315","02616","BK1574","09966","BK1161","02617"],"gpt_icon":0},{"id":"2576844540","title":"ETF龙虎榜 | 6只产品跻身涨幅前十！这类ETF普涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2576844540","media":"东方财富","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576844540?lang=zh_cn&edition=fundamental","pubTime":"2025-10-16 22:22","pubTimestamp":1760624566,"startTime":"0","endTime":"0","summary":"0210月16日，港股创新药主题ETF普涨，6只基金跻身ETF涨幅榜前十，涨幅均超2%。此外，2只跨境ETF以及1只主投煤炭领域的ETF涨幅居前。有4只ETF单日获净流入额超10亿元，涵盖主投黄金、稀土、沪深300等领域的产品，以及货基ETF。全市场ETF跌幅前四均为稀土ETF，单日跌幅均超过2%。此外，多只机器人主题ETF也出现不同程度下跌。ETF单日资金净流入额超100亿元10月15日，全市场ETF单日资金净流入额为108亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510162223049731fd4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510162223049731fd4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","BK1161","02617","BK1574"],"gpt_icon":0},{"id":"2575710563","title":"妖股，“卷土重来”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2575710563","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575710563?lang=zh_cn&edition=fundamental","pubTime":"2025-10-16 18:47","pubTimestamp":1760611620,"startTime":"0","endTime":"0","summary":"　　今日，港股三大指数表现不一。红利板块整体走强，恒生国企指数收涨；汽车、半导体、科网股下跌，拖累恒生指数表现。“妖股”药捷安康再度上演股价“蹦极”。　　10月16日，港股三大指数早盘一度下挫，午盘回暖。截至收盘，恒生国企指数上涨0.09%，恒生指数微跌0.09%，恒生科技指数跌超1%。经核实，该传言不属实。　　药捷安康-B暴涨46.34%，盘中最大涨幅达55%。　　药捷安康于6月23日登陆港股市场，仍是次新“小盘股”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2025-10-16/doc-infuauti2455774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02617","HSImain","513600","MCHmain","BK1161","HHImain","HSI","02833"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":190,"code":"91000000","status":"200"}]}}